ICD-10-CM Code R89.1

Abnormal level of hormones in specimens from other organs, systems and tissues

Version 2020 Billable Code No Valid Principal Dx

Valid for Submission

R89.1 is a billable code used to specify a medical diagnosis of abnormal level of hormones in specimens from other organs, systems and tissues. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code R89.1 might also be used to specify conditions or terms like abnormal 11-deoxy, 17-hydroxycorticosterone, abnormal 11-deoxycorticosterone, abnormal 17-ketogenic steroids, abnormal 17-ketosteroids, abnormal 3,3' diiodothyronine, abnormal adrenal cortical hormone, etc

According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.

ICD-10:R89.1
Short Description:Abnormal level of hormones in specimens from oth org/tiss
Long Description:Abnormal level of hormones in specimens from other organs, systems and tissues

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R89.1 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal 11-deoxy, 17-hydroxycorticosterone
  • Abnormal 11-deoxycorticosterone
  • Abnormal 17-ketogenic steroids
  • Abnormal 17-ketosteroids
  • Abnormal 3,3' diiodothyronine
  • Abnormal adrenal cortical hormone
  • Abnormal adrenocorticotropic hormone
  • Abnormal anti-diuretic hormone
  • Abnormal corticotropin releasing factor
  • Abnormal cortisone
  • Abnormal epinephrine
  • Abnormal glucagon
  • Abnormal human chorionic gonadotropin
  • Abnormal human growth hormone
  • Abnormal melanocyte stimulating hormone
  • Abnormal norepinephrine
  • Abnormal oxytocin
  • Abnormal pituitary follicle stimulating hormone
  • Abnormal pituitary gonadotropin
  • Abnormal pituitary luteinizing hormone
  • Abnormal polypeptide hormone
  • Abnormal pregnanediol
  • Abnormal protein hormone
  • Abnormal secretin
  • Abnormal steroid hormone
  • Abnormal thyroxine
  • Abnormal triiodothyronine
  • Abnormal vanillylmandelic acid
  • Cortisol level abnormal
  • Decreased 11-deoxy, 17-hydroxycorticosterone level
  • Decreased 11-deoxycorticosterone level
  • Decreased 17-ketogenic steroids level
  • Decreased 17-ketosteroids level
  • Decreased 3,3' diiothyronine level
  • Decreased adrenal cortical hormone level
  • Decreased adrenocorticotropic hormone level
  • Decreased androgen level
  • Decreased anti-diuretic hormone level
  • Decreased corticosterone level
  • Decreased corticotropin releasing factor level
  • Decreased cortisol level
  • Decreased cortisone level
  • Decreased epinephrine level
  • Decreased estradiol level
  • Decreased estriol level
  • Decreased estrone level
  • Decreased glucagon level
  • Decreased human chorionic gonadotropin level
  • Decreased human growth hormone level
  • Decreased insulin level
  • Decreased melanocyte stimulating hormone level
  • Decreased norepinephrine level
  • Decreased oxytocin level
  • Decreased pituitary follicle stimulating hormone
  • Decreased pituitary gonadotropin level
  • Decreased pituitary luteinizing hormone level
  • Decreased polypeptide hormone level
  • Decreased pregnanediol level
  • Decreased pregnanetriol level
  • Decreased progesterone level
  • Decreased prolactin level
  • Decreased protein hormone level
  • Decreased secretin level
  • Decreased thyroid hormone level
  • Decreased thyroid stimulating hormone level
  • Decreased thyroxine level
  • Decreased triiodothyronine level
  • Female sex hormones abnormal
  • Fetoplacental hormones abnormal
  • Free androgenic index abnormal
  • FSH level abnormal
  • Gonadotrophin level borderline high
  • Gonadotrophin level borderline low
  • Gonadotrophin levels low
  • Gonadotrophin levels raised
  • Hormone abnormality
  • Hormone absence
  • Hormone decrease
  • Hormone increase
  • HPL - Human placental lactogen abnormal
  • Increased 11-deoxy, 17-hydroxycorticosterone level
  • Increased 11-deoxycorticosterone level
  • Increased 17-ketogenic steroids level
  • Increased 17-ketosteroids level
  • Increased 3,3' diiothyronine level
  • Increased adrenal cortical hormone level
  • Increased adrenocorticotropic hormone level
  • Increased anti-diuretic hormone level
  • Increased corticosterone level
  • Increased corticotropin releasing factor level
  • Increased epinephrine level
  • Increased estradiol level
  • Increased estriol level
  • Increased estrone level
  • Increased glucagon level
  • Increased human chorionic gonadotropin level
  • Increased human growth hormone level
  • Increased insulin level
  • Increased melanocyte stimulating hormone level
  • Increased norepinephrine level
  • Increased oxytocin level
  • Increased pituitary follicle stimulating hormone level
  • Increased pituitary gonadotropin level
  • Increased pituitary luteinizing hormone level
  • Increased polypeptide hormone level
  • Increased pregnanediol level
  • Increased progesterone level
  • Increased prolactin level
  • Increased protein hormone level
  • Increased secretin level
  • Increased thyroid hormone level
  • Increased thyroxine level
  • Increased triiodothyronine level
  • LH level abnormal
  • Male sex hormones borderline high
  • Male sex hormones borderline low
  • Male sex hormones low
  • Male sex hormones raised
  • T3 uptake test abnormal
  • Thyroid hormone borderline high
  • Thyroid hormone borderline low

Diagnostic Related Groups

The ICD-10 code R89.1 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 947 - SIGNS AND SYMPTOMS WITH MCC
  • 948 - SIGNS AND SYMPTOMS WITHOUT MCC

Convert R89.1 to ICD-9

  • 792.9 - Abn find-body subst NEC (Approximate Flag)

Code Classification

  • Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00–R99)
    • Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)
      • Abnormal findings in specimens from oth org/tiss (R89)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020